These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2594873

  • 1. Dexamethasone suppression test in positive and negative schizophrenia.
    Altamura C, Guercetti G, Percudani M.
    Psychiatry Res; 1989 Oct; 30(1):69-75. PubMed ID: 2594873
    [Abstract] [Full Text] [Related]

  • 2. Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels.
    Holsboer-Trachsler E, Buol C, Wiedemann K, Holsboer F.
    Acta Psychiatr Scand; 1987 Jun; 75(6):608-13. PubMed ID: 3618283
    [Abstract] [Full Text] [Related]

  • 3. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms.
    Pivac N, Mück-Seler D, Jakovljević M.
    Neuropsychobiology; 1997 Jun; 36(1):19-21. PubMed ID: 9211439
    [Abstract] [Full Text] [Related]

  • 4. Monoamine oxidase and cortisol response in depression and schizophrenia.
    Pandey GN, Sharma RP, Janicak PG, Davis JM.
    Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
    [Abstract] [Full Text] [Related]

  • 5. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia.
    Jakovljević M, Mück-Seler D, Pivac N, Crncević Z.
    Neuropsychobiology; 1998 Oct; 37(3):142-5. PubMed ID: 9597670
    [Abstract] [Full Text] [Related]

  • 6. [Dexamethasone suppression test and the positive and negative symptoms of schizophrenia].
    Rybakowski J, Linka M, Matkowski K, Kanarkowski R.
    Psychiatr Pol; 1991 Oct; 25(5):9-15. PubMed ID: 1821997
    [Abstract] [Full Text] [Related]

  • 7. Dexamethasone suppression test in schizophrenic patients: report from India.
    Joseph S, Kulhara P, Dash RJ.
    Biol Psychiatry; 1987 Jun; 22(6):792-5. PubMed ID: 3593821
    [No Abstract] [Full Text] [Related]

  • 8. Platelet serotonin, plasma cortisol, and dexamethasone suppression test in schizophrenic patients.
    Mück-Seler D, Pivac N, Jakovljević M, Brzović Z.
    Biol Psychiatry; 1999 Jun 01; 45(11):1433-9. PubMed ID: 10356625
    [Abstract] [Full Text] [Related]

  • 9. Cognitive impairment and cortisol levels in first-episode schizophrenia patients.
    Havelka D, Prikrylova-Kucerova H, Prikryl R, Ceskova E.
    Stress; 2016 Jul 01; 19(4):383-9. PubMed ID: 27320489
    [Abstract] [Full Text] [Related]

  • 10. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 Aug 01; 49(2):165-71. PubMed ID: 9828902
    [Abstract] [Full Text] [Related]

  • 11. Dexamethasone suppression test in schizophrenia: its relation to monoamine metabolism in hypothalamic-pituitary-adrenal axis.
    Kaneko M, Murata S, Hoshino Y, Takahagi K, Yokoyama F, Watanabe M, Kumashiro H.
    Neuropsychobiology; 1998 Aug 01; 24(1):12-6. PubMed ID: 2132636
    [Abstract] [Full Text] [Related]

  • 12. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF, Prudic J, Rothpearl A, Nurnberg HG.
    J Affect Disord; 1985 Sep 01; 9(2):107-13. PubMed ID: 2932482
    [Abstract] [Full Text] [Related]

  • 13. Hypothalamic-pituitary-adrenal axis in schizophrenia.
    Altamura AC.
    Biol Psychiatry; 1996 Sep 15; 40(6):560-1. PubMed ID: 8879482
    [No Abstract] [Full Text] [Related]

  • 14. The dexamethasone suppression test in patients with postpsychotic depressions.
    Siris SG, Rifkin A, Reardon GT, Doddi SR, Foster P, Strahan A, Morgan V.
    Biol Psychiatry; 1984 Sep 15; 19(9):1351-6. PubMed ID: 6498257
    [No Abstract] [Full Text] [Related]

  • 15. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
    Pfohl B, Sherman B, Schlechte J, Stone R.
    Arch Gen Psychiatry; 1985 Sep 15; 42(9):897-903. PubMed ID: 2994590
    [Abstract] [Full Text] [Related]

  • 16. The metyrapone test in schizophrenic patients and healthy subjects.
    Morphy MA, Fava GA, Carson SW, Perini GI, Molnar G, Jusko WJ.
    Neuropsychobiology; 1985 Sep 15; 14(1):35-8. PubMed ID: 4069347
    [Abstract] [Full Text] [Related]

  • 17. Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatment.
    Wik G, Wiesel FA, Eneroth P, Sedvall G, Aström G.
    Acta Psychiatr Scand; 1986 Aug 15; 74(2):161-7. PubMed ID: 2877544
    [Abstract] [Full Text] [Related]

  • 18. Dexamethasone suppression test, schizophrenia and movement disorder.
    Aleem A, Kulkarni A, Yeragani VK.
    Acta Psychiatr Scand; 1988 Dec 15; 78(6):689-94. PubMed ID: 3223326
    [Abstract] [Full Text] [Related]

  • 19. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
    Lammers CH, Garcia-Borreguero D, Schmider J, Gotthardt U, Dettling M, Holsboer F, Heuser IJ.
    Biol Psychiatry; 1995 Dec 15; 38(12):803-7. PubMed ID: 8750038
    [Abstract] [Full Text] [Related]

  • 20. Noradrenergic function and the cortisol response to dexamethasone in depression.
    Rubin AL, Price LH, Charney DS, Heninger GR.
    Psychiatry Res; 1985 May 15; 15(1):5-15. PubMed ID: 2989963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.